News

Eli Lilly has rolled out a prefilled pen version of its weight-loss drug Mounjaro at the same price as vials, aiming to ...
Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced its financial results for the second quarter and provided a business update.
In India, home to 74 million diabetes patients, a range of supplements is being marketed as natural GLP-1 alternatives, but ...
(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...
Eli Lilly introduces its Mounjaro Kwikpen in India at ₹14,000 for the 2.5 mg starting dose, competing with Novo Nordisk’s Wegovy in the booming GLP-1 drug market for diabetes and weight loss.
Waiting a month for his insurance company to approve his insulin medication, Timothy Dontigney could not afford to pay for the medication upfront and had to go for a time without it, a dangerous ...
Eli Lilly launches Mounjaro KwikPen in India, offering adults with type 2 diabetes and obesity a once-weekly, ...
Women who took part in a weight loss programme had a 21 per cent higher chance of becoming pregnant – whether naturally or through IVF ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Eli Lilly has launched pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving more options for those ...
FOR years, Emma Morris hid from cameras, avoided mirrors and felt like a prisoner in her own body because of her weight. But ...
A WOMAN who has lost almost four stone on Mounjaro has admitted there are more than a few downsides. Sara-Jane has been on ...